169 related articles for article (PubMed ID: 29148317)
21. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
Chaichana KL; McGirt MJ; Niranjan A; Olivi A; Burger PC; Quinones-Hinojosa A
Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
[TBL] [Abstract][Full Text] [Related]
22. Correlation among magnetic resonance imaging findings, prognostic factors for survival, and histological diagnosis of intrinsic brainstem lesions in children.
Dellaretti M; Touzet G; Reyns N; Dubois F; Gusmão S; Pereira JL; Blond S
J Neurosurg Pediatr; 2011 Dec; 8(6):539-43. PubMed ID: 22132909
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
Boxerman JL; Ellingson BM; Jeyapalan S; Elinzano H; Harris RJ; Rogg JM; Pope WB; Safran H
Am J Clin Oncol; 2017 Jun; 40(3):228-234. PubMed ID: 25436828
[TBL] [Abstract][Full Text] [Related]
24. Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings.
Narang AK; Chaichana KL; Weingart JD; Redmond KJ; Lim M; Olivi A; Quinones-Hinojosa A; Kleinberg LR
World Neurosurg; 2017 Mar; 99():751-757. PubMed ID: 27108796
[TBL] [Abstract][Full Text] [Related]
25. MRI patterns of T1 enhancing radiation necrosis versus tumour recurrence in high-grade gliomas.
Reddy K; Westerly D; Chen C
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):349-55. PubMed ID: 23721146
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
27. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.
Villanueva-Meyer JE; Wood MD; Choi BS; Mabray MC; Butowski NA; Tihan T; Cha S
AJR Am J Roentgenol; 2018 Mar; 210(3):621-628. PubMed ID: 29261348
[TBL] [Abstract][Full Text] [Related]
28. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
29. Correlation of
Zukotynski KA; Vajapeyam S; Fahey FH; Kocak M; Brown D; Ricci KI; Onar-Thomas A; Fouladi M; Poussaint TY
J Nucl Med; 2017 Aug; 58(8):1264-1269. PubMed ID: 28360212
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of MRI texture analysis for grading gliomas.
Ditmer A; Zhang B; Shujaat T; Pavlina A; Luibrand N; Gaskill-Shipley M; Vagal A
J Neurooncol; 2018 Dec; 140(3):583-589. PubMed ID: 30145731
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of Recurrent/Residual Glioma From Radiation Necrosis Using Semi Quantitative 99mTc MDM (Bis-Methionine-DTPA) Brain SPECT/CT and Dynamic Susceptibility Contrast-Enhanced MR Perfusion: A Comparative Study.
Rani N; Singh B; Kumar N; Singh P; Hazari PP; Singh H; Kumar G; Radotra B; Kumar M; Bhattacharya A; Sharma R; Kohli A; Chhabra R; Gupta SK; Mishra AK
Clin Nucl Med; 2018 Mar; 43(3):e74-e81. PubMed ID: 29356734
[TBL] [Abstract][Full Text] [Related]
32. Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.
Cihangiroglu MM; Ozturk-Isik E; Firat Z; Kilickesmez O; Ulug AM; Ture U
Diagn Interv Imaging; 2017 Mar; 98(3):261-268. PubMed ID: 28038915
[TBL] [Abstract][Full Text] [Related]
33. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
[TBL] [Abstract][Full Text] [Related]
34. The value of 201thallium-SPECT imaging in childhood brainstem gliomas.
Nadvi SS; Ebrahim FS; Corr P
Pediatr Radiol; 1998 Aug; 28(8):575-9. PubMed ID: 9716624
[TBL] [Abstract][Full Text] [Related]
35. Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only.
Rachinger W; Grau S; Holtmannspötter M; Herms J; Tonn JC; Kreth FW
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1134-9. PubMed ID: 19520698
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
37. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
38. A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1.
Mahdi J; Shah AC; Sato A; Morris SM; McKinstry RC; Listernick R; Packer RJ; Fisher MJ; Gutmann DH
Neurology; 2017 Apr; 88(16):1584-1589. PubMed ID: 28330960
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma.
Rapp M; Heinzel A; Galldiks N; Stoffels G; Felsberg J; Ewelt C; Sabel M; Steiger HJ; Reifenberger G; Beez T; Coenen HH; Floeth FW; Langen KJ
J Nucl Med; 2013 Feb; 54(2):229-35. PubMed ID: 23232275
[TBL] [Abstract][Full Text] [Related]
40. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
